Mediphage Bioceuticals Competitors and Similar CompaniesClear all

Mediphage Bioceuticals's competitors and similar companies include Cell Therapies, Ambrx, Ethris and ProQR Therapeutics.

	Mediphage Bioceuticals Mediphage Bioceuticals is a genetic medicine company developing a non-viral gene delivery vector platform.	Cell Therapies Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products.	Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.	Ethris Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia.	ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
Founding Date	Founding Date 2016	Founding Date 2003	Founding Date 2003	Founding Date 2009	Founding Date 2012
Type	Type Private	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy
Locations	Locations Toronto, CA HQ	Locations Melbourne, AU HQ	Locations San Diego, US HQ	Locations Planegg, DE HQ	Locations Leiden, NL HQ Cambridge, US
Employees	Employees 1023% decrease	Employees 733% decrease	Employees 70	Employees 504% decrease	Employees 166
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 1.8 b	Valuation ($) N/A	Valuation ($) 281.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $7.4m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) €15.9m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income ($78m) (FY, 2022)	Net income N/A	Net income (€42.2m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 4.1m	Total funding raised N/A	Total funding raised $ 347.9m	Total funding raised N/A	Total funding raised $ 57.8m